BetterScholar BetterScholar

J. Andreu

Clinical Cancer Research, Radiographics, International Immunopharmacology, AJR. American journal of roentgenology, Gastroenterology, Head and Neck, Journal of Urology Show more
9
Role
Title
Level Year L/R
🐜 Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency.
9 auth. J. de Gracia, M. Vendrell, A. Álvarez, E. Pallisa, M. Rodrigo, D. de la Rosa, ... F. Mata, J. Andreu, F. Morell 		7 2004
7
🐜
🐜 Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors
17 auth. A. Cervantes, E. Élez, D. Roda, J. Ecsedy, T. Macarulla, K. Venkatakrishnan, S. Roselló, J. Andreu, JungAh Jung, Juan Manuel Sanchís-García, ... A. Piera, I. Blasco, L. Manos, J. Pérez-Fidalgo, H. Fingert, J. Baselga, J. Tabernero 		7 2012
7
🐜
🐜 A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors
21 auth. F. Atzori, J. Tabernero, A. Cervantes, L. Prudkin, J. Andreu, E. Rodríguez-Braun, A. Domingo, J. Guijarro, C. Gamez, J. Rodón, ... S. Di Cosimo, H. Brown, Jason Clark, J. Hardwick, R. Beckman, W. Hanley, K. Hsu, E. Calvo, S. Roselló, R. B. Langdon, J. Baselga 		6 2011
6
🐜
🐬 Lymphangioleiomyomatosis: pulmonary and abdominal findings with pathologic correlation.
E. Pallisa, P. Sanz, A. Roman, J. Majó, J. Andreu, J. Cáceres 		6 2002
6
🐬
🐬 Epipericardial fat necrosis: radiologic diagnosis and follow-up.
V. Pineda, J. Cáceres, J. Andreu, J. Vilar, M. Domingo 		6 2005
6
🐬
🐬 Bowel habit after cholecystectomy: physiological changes and clinical implications.
JM Fort, F. Azpiroz, F. Casellas, J. Andreu, J. Malagelada 		6 1996
6
🐬
🐜 Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab‐based therapy
8 auth. A. Prat, M. Parera, V. Reyes, S. Peralta, S. Cedres, J. Andreu, ... P. Huguet, J. D. Del Campo 		6 2008
6
🐜
🐢 Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
7 auth. Juan Morote, C. Raventós, José A. Lorente, López-Pacios Ma, Gloria Encabo, I. Torres, ... J. Andreu 		6 1997
6
🐢
🐬 Lesions of the cardiophrenic space: findings at cross-sectional imaging.
V. Pineda, J. Andreu, J. Cáceres, X. Merino, D. Varona, R. Domínguez-Oronoz 		6 2007
6
🐬